Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: A children's oncology group phase 2 study

Authors

Kristin A. Bradley, University Hospital and Clinics, Madison, WI
Tianni Zhou, University of Southern California
Rene Y. McNall-Knapp, University of Oklahoma
Regina I. Jakacki, Children's Hospital of Pittsburgh, Pittsburgh, PA
Adam S. Levy, Albert Einstein College of Medicine, Bronx, NY
Gilbert Vezina, George Washington UniversityFollow
Ian F. Pollack, University of Pittsburgh

Document Type

Journal Article

Publication Date

1-1-2013

Journal

International Journal of Radiation Oncology Biology Physics

Volume

Volume 85, Issue 1

Inclusive Pages

e55-e60

Keywords

Brain Stem Neoplasms--radiotherapy; Glioma--radiotherapy; Metalloporphyrins--therapeutic use; Pons; Radiation-Sensitizing Agents--therapeutic use

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Bradley, K. A., Zhou, T., McNall-Knapp, R. Y., Jakacki, R. I., Levy, A. S., Vezina, G., & Pollack, I. F. (2013). Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: A children's oncology group phase 2 study. International Journal of Radiation Oncology Biology Physics, 85(1), e55-e60.

Peer Reviewed

1

Open Access

1